272 related articles for article (PubMed ID: 22995295)
1. Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress.
Tsuda H; Kawada N; Kaimori JY; Kitamura H; Moriyama T; Rakugi H; Takahara S; Isaka Y
Biochem Biophys Res Commun; 2012 Oct; 427(2):266-72. PubMed ID: 22995295
[TBL] [Abstract][Full Text] [Related]
2. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
[TBL] [Abstract][Full Text] [Related]
3. Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy.
Omori H; Kawada N; Inoue K; Ueda Y; Yamamoto R; Matsui I; Kaimori J; Takabatake Y; Moriyama T; Isaka Y; Rakugi H
Clin Exp Nephrol; 2012 Aug; 16(4):549-56. PubMed ID: 22350467
[TBL] [Abstract][Full Text] [Related]
4. Cardio-renal protective effect of the xanthine oxidase inhibitor febuxostat in the 5/6 nephrectomy model with hyperuricemia.
Omizo H; Tamura Y; Morimoto C; Ueno M; Hayama Y; Kuribayashi-Okuma E; Uchida S; Shibata S
Sci Rep; 2020 Jun; 10(1):9326. PubMed ID: 32518351
[TBL] [Abstract][Full Text] [Related]
5. Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation.
Sabán-Ruiz J; Alonso-Pacho A; Fabregate-Fuente M; de la Puerta González-Quevedo C
Antiinflamm Antiallergy Agents Med Chem; 2013; 12(1):94-9. PubMed ID: 23286293
[TBL] [Abstract][Full Text] [Related]
6. Superior protective effects of febuxostat plus alpha-lipoic acid on renal ischemia/reperfusion-induced hepatorenal injury in rats.
Farag MM; Ahmed SM; Elhadidy WF; Rashad RM
Saudi J Kidney Dis Transpl; 2019; 30(6):1364-1374. PubMed ID: 31929283
[TBL] [Abstract][Full Text] [Related]
7. Osthole ameliorates renal ischemia-reperfusion injury in rats.
Zheng Y; Lu M; Ma L; Zhang S; Qiu M; Wang Y
J Surg Res; 2013 Jul; 183(1):347-54. PubMed ID: 23391166
[TBL] [Abstract][Full Text] [Related]
8. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.
Takano Y; Hase-Aoki K; Horiuchi H; Zhao L; Kasahara Y; Kondo S; Becker MA
Life Sci; 2005 Mar; 76(16):1835-47. PubMed ID: 15698861
[TBL] [Abstract][Full Text] [Related]
9. Prevention of renal ischemia/reperfusion-induced injury in rats by leflunomide.
Karaman A; Turkmen E; Gursul C; Tas E; Fadillioglu E
Int J Urol; 2006 Nov; 13(11):1434-41. PubMed ID: 17083399
[TBL] [Abstract][Full Text] [Related]
10. The Protective Effect of Febuxostat on Chronic Tacrolimus-Induced Nephrotoxicity in Rats.
Kim HS; Lim SW; Jin L; Jin J; Chung BH; Yang CW
Nephron; 2017; 135(1):61-71. PubMed ID: 27701176
[TBL] [Abstract][Full Text] [Related]
11. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
12. Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
Fahmi AN; Shehatou GS; Shebl AM; Salem HA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):819-30. PubMed ID: 27215580
[TBL] [Abstract][Full Text] [Related]
13. Renal protective effect of molsidomine and L-arginine in ischemia-reperfusion induced injury in rats.
Chander V; Chopra K
J Surg Res; 2005 Sep; 128(1):132-9. PubMed ID: 15936772
[TBL] [Abstract][Full Text] [Related]
14. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress.
Ji L; Fu F; Zhang L; Liu W; Cai X; Zhang L; Zheng Q; Zhang H; Gao F
Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E871-80. PubMed ID: 20124508
[TBL] [Abstract][Full Text] [Related]
15. Tissue protective effect of xanthine oxidase inhibitor, polymer conjugate of (styrene-maleic acid copolymer) and (4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine), on hepatic ischemia-reperfusion injury.
Fang J; Seki T; Qin H; Bharate GY; Iyer AK; Maeda H
Exp Biol Med (Maywood); 2010 Apr; 235(4):487-96. PubMed ID: 20407081
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of aliskiren on ischemia-reperfusion-induced renal injury in rats.
Wang Z; Liu Y; Han Y; Guan W; Kou X; Fu J; Yang D; Ren H; He D; Zhou L; Zeng C
Eur J Pharmacol; 2013 Oct; 718(1-3):160-6. PubMed ID: 24041923
[TBL] [Abstract][Full Text] [Related]
17. [The role of xanthine dehydrogenase (xanthine oxidase) in ischemia-reperfusion injury in rat kidney].
Okabe H
Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):577-84. PubMed ID: 9014477
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species differently regulate renal tubular epithelial and interstitial cell proliferation after ischemia and reperfusion injury.
Kim J; Jung KJ; Park KM
Am J Physiol Renal Physiol; 2010 May; 298(5):F1118-29. PubMed ID: 20164154
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide.
Sun Z; Zhang X; Ito K; Li Y; Montgomery RA; Tachibana S; Williams GM
Am J Physiol Renal Physiol; 2008 Mar; 294(3):F491-8. PubMed ID: 18160622
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation.
Hu L; Yang C; Zhao T; Xu M; Tang Q; Yang B; Rong R; Zhu T
J Surg Res; 2012 Jul; 176(1):260-6. PubMed ID: 21816412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
